Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 170 (RN7SKP170) is a non-functional genomic DNA sequence in the human genome classified as a pseudogene related to the **RN7SK small nuclear RNA** gene family[3]. Unlike the functional RN7SK gene, which encodes a small nuclear RNA critical for the regulation of the transcription elongation factor P-TEFb and is important for gene transcription and cell cycle control[1][4][2], RN7SKP170 does not produce a product involved in these processes. It is annotated in genome databases but no evidence supports its involvement in gene expression, protein production, or any cellular pathway. RN7SKP170 is not a drug target and is not associated with any known disease or therapeutic response, nor is it used as a biomarker. The correct **therapeutically relevant target** in this family is the **RN7SK small nuclear RNA**, not the pseudogene[1][4][2]. If the intent was to target small nuclear RNA regulatory complexes, refer to "RN7SK small nuclear RNA" or "7SK snRNA."
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 170 (RN7SKP170).